"10.1371_journal.pone.0140880","plos one","2015-10-20T00:00:00Z","Abid Oueslati; Blaise Lovisa; John Perrin; Georges Wagnières; Hubert van den Bergh; Yanik Tardy; Hilal A Lashuel","Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Swiss Federal Institute of Technology (EPFL), CH-1015, Lausanne, Switzerland; Centre de Recherche du Centre Hospitalier de Québec, Axe Neuroscience et Département de Médecine Moléculaire de lUniversité Laval, Québec, G1V4G2, Canada; Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology (EPFL), CH-1015, Lausanne, Switzerland; Medos International Sàrl, a Johnson&Johnson company, Chemin Blanc 38, CH-2400, Le Locle, Switzerland; Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, P.O. Box 5825, Doha, Qatar","Conceived and designed the experiments: AO HAL BL GW HvdB. Performed the experiments: AO BL JP. Analyzed the data: AO HAL BL GW HvdB YT. Wrote the paper: AO HAL.","The authors have declared that no competing interests exist. We have the following interests: This work was in part supported by Medos International Sàrl, a Johnson&Johnson company. Co-authors Blaise Lovisa and Yanik Tardy are employed by Medos International Sàrl, a Johnson&Johnson company. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","10","Abid Oueslati","AO",7,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
